Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace?

Louis P Perrault1, Alan J Moskowitz, Irving L Kron

  • 1Department of Surgery, Montreal Heart Institute, University of Montréal, Montréal, Québec, Canada.

Insights

This study designs a clinical trial for ischemic mitral regurgitation, comparing mitral valve repair versus replacement. Evidence is needed to guide treatment choices for this high-mortality condition.

Area of Science:

  • Cardiovascular Surgery
  • Clinical Trials
  • Heart Valve Disease

Background:

  • Ischemic mitral regurgitation affects 2.8 million Americans, a complication of coronary artery disease with high mortality.
  • Current guidelines recommend mitral valve repair or replacement, but evidence comparing interventions is lacking.
  • Treatment decisions involve a trade-off between operative risk and long-term effectiveness, leading to varied surgical practices.

Purpose of the Study:

  • To design a prospective randomized clinical trial evaluating mitral valve repair versus replacement for severe ischemic mitral regurgitation.
  • To address challenges in defining primary endpoints, patient selection, and analytical strategies for this high-mortality disease.

Main Methods:

  • Prospective randomized clinical trial design.
  • Focus on evaluating safety and effectiveness of mitral valve repair and replacement.
  • Part of the Cardiothoracic Surgical Trials Network.

Main Results:

  • The article details the trial design, not preliminary results.
  • Challenges in endpoint selection and patient characterization are discussed.
  • Analytical considerations for high-mortality disease are addressed.

Conclusions:

  • The trial aims to provide crucial data for therapeutic decision-making.
  • Information on functional status, survival, neurocognition, quality of life, and cardiac physiology will be gathered.
  • Findings will inform optimal surgical strategies for ischemic mitral regurgitation.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...